智通财经APP获悉，大和发布研报称，创科实业(00669)中期业绩表现稳健，EBIT利润率同比提升86个基点至9.9%，非常接近管理层2027年达到10%的内部目标。利润率显著优于预期，推动上半年盈利增长17.5%至7.38亿美元，较市场预期高出3%。该行重申创科的“买入”评级，目标价由143港元上调至170港元。
报告又指，管理层透露上半年利润率还未计及潜在的关税退税，预期退税可能于今年下半年带来一次性收益。大和认为，创科有望提早一年达成10% EBIT利润率目标，在未计入关税退税潜在一次性收益的情况下2026年已可达标。随着利润率较高的Milwaukee品牌占比持续提升，以及其他小型品牌拖累减少，大和预期创科实业2026至2028年利润率持续扩张有较高度可见度，将2026至2028年每股盈利预测上调4%至5%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.